Precision Optics Corporation, Inc. (NASDAQ:POCI), a leading designer and manufacturer of advanced optical instruments for the medical and defense/aerospace industries, today announced the pricing of its previously announced underwritten public offering of 2,777,777 shares of its common stock at a public offering price of $3.60 per share, before deducting underwriting discounts and commissions and offering expenses.

The oversubscribed offering was led by a mix of existing and new fundamental institutional investors and included participation from directors, officers and executive management of the company including Dr. Joseph N. Forkey, the company's President, Chief Executive Officer and member of its Board of Directors, Wayne Coll, the company's Chief Financial Officer, and Joseph Traut, the company's Chief Operating Officer, who each purchased shares of common stock in this offering at the public offering price and on the same terms as the other purchasers in this offering.

Lucid Capital Markets is acting as the sole book-running manager for the offering.

All of the shares of common stock to be sold in the offering will be sold by the Company. In addition, the Company has granted the underwriter a 45-day option to purchase up to an additional 416,667 shares of its common stock at the public offering price less the underwriting discounts and commissions. The offering is expected to close on or about March 30, 2026, subject to customary closing conditions.

The Company intends to use net proceeds from this offering for working capital and general corporate purposes. The offering is being made pursuant to a shelf registration statement on Form S-3 (File No. 333-280047) filed with the Securities and Exchange Commission ("SEC") on June 7, 2024, as amended on June 11, 2024, and declared effective by the SEC on June 14, 2024.